Literature DB >> 20518779

Can sebum reduction predict acne outcome?

N Janiczek-Dolphin1, J Cook, D Thiboutot, J Harness, A Clucas.   

Abstract

Sebum excretion has generally been accepted as an important factor in the development of acne vulgaris. However, the relationship of sebum excretion and acne outcome has not yet been clearly demonstrated quantitatively. The objective of this analysis was to explore the correlation of sebum and acne by combining data from studies of various acne treatments that have demonstrated effects on both sebum excretion and acne outcome. Acne measures included total lesion count, inflammatory lesion count and acne severity grade. For each acne measure, data were pooled and analysed at the 3- and 4-month endpoints, when sebum reduction has generally equilibrated and efficacy in acne is approaching the maximum effect for most treatments. A linear model was used to describe the percentage reduction in each acne measure as a function of percentage reduction in sebum excretion. Slope values were similar for the three acne parameters and all were significantly different from zero (P < 0·025), suggesting a significant correlation of sebum and acne. The projected sebum reduction required to achieve 50% reduction in acne measures ranged from 30% to 50%. The results shown here suggest that the collective data across multiple studies may provide a useful generalization of the association of sebum reduction and acne outcome. As the relationship apparently remains consistent regardless of the treatment, it can be inferred that extrapolation to novel exploratory treatments may be valid.
© 2010 Pfizer, Inc. Journal Compilation © 2010 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2010        PMID: 20518779     DOI: 10.1111/j.1365-2133.2010.09878.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Selective Cryolysis of Sebaceous Glands.

Authors:  H Ray Jalian; Joshua Tam; Linh N Vuong; Jeremy Fisher; Lilit Garibyan; Martin C Mihm; David Zurakowski; Conor L Evans; R Rox Anderson
Journal:  J Invest Dermatol       Date:  2015-04-10       Impact factor: 8.551

2.  The skin function: a factor of anti-metabolic syndrome.

Authors:  Shi-Sheng Zhou; Da Li; Yi-Ming Zhou; Ji-Min Cao
Journal:  Diabetol Metab Syndr       Date:  2012-04-26       Impact factor: 3.320

3.  A Phase 1 Randomized, Placebo-Controlled Trial With a Topical Inhibitor of Stearoyl-Coenzyme A Desaturase 1 Under Occluded and Nonoccluded Conditions.

Authors:  Richard A Brigandi; John Zhu; Amy A Murnane; Beth Ann Reedy; Sepehr Shakib
Journal:  Clin Pharmacol Drug Dev       Date:  2019-01-16

4.  Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial.

Authors:  Agnieszka Kaźmierska; Izabela Bolesławska; Adriana Polańska; Aleksandra Dańczak-Pazdrowska; Paweł Jagielski; Sławomira Drzymała-Czyż; Zygmunt Adamski; Juliusz Przysławski
Journal:  Nutrients       Date:  2022-07-21       Impact factor: 6.706

5.  Sebusuppressive efficacy of the antioxidant bis-ethylhexyl hydroxydimethoxy benzylmalonate in the treatment of oily and blemished skin.

Authors:  Nicole Gerlach; Ruediger Graf; Gabriele Witte; Marina Lefort; Frank Pfluecker; Ulrike Heinrich; Hagen Tronnier
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-08-20

6.  Liposomal encapsulated rhodomyrtone: a novel antiacne drug.

Authors:  Julalak Chorachoo; Thanaporn Amnuaikit; Supayang P Voravuthikunchai
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-16       Impact factor: 2.629

7.  Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin.

Authors:  Małgorzata L Kmieć; Anna Pajor; Grażyna Broniarczyk-Dyła
Journal:  Postepy Dermatol Alergol       Date:  2013-12-18       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.